<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE CONSOLIDATED BALANCE SHEETS AND CONSOLIDATED STATEMENTS OF OPERATIONS OF U.S. BIOSCIENCE, INC. FOR THE PERIOD(S) INDICATED AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <PERIOD-TYPE> 3-MOS <FISCAL-YEAR-END> DEC-31-1996 <PERIOD-END> MAR-31-1996 <CASH> 43,770,000 <SECURITIES> 3,002,700 <RECEIVABLES> 1,730,800 <ALLOWANCES> 128,900 <INVENTORY> 2,295,400 <CURRENT-ASSETS> 52,126,700 <PP&E> 10,247,900 <DEPRECIATION> 4,182,100 <TOTAL-ASSETS> 58,192,500 <CURRENT-LIABILITIES> 12,360,500 <BONDS> 12,304,600 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 218,900 <OTHER-SE> 33,308,500 <TOTAL-LIABILITY-AND-EQUITY> 58,192,500 <SALES> 2,962,600 <TOTAL-REVENUES> 3,826,500 <CGS> 873,500 <TOTAL-COSTS> 6,929,900 <OTHER-EXPENSES> 0 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 329,800 <INCOME-PRETAX> (3,433,200) <INCOME-TAX> 0 <INCOME-CONTINUING> (3,433,200) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (3,433,200) <EPS-PRIMARY> (0.16) <EPS-DILUTED> (0.16)